Provided by Tiger Trade Technology Pte. Ltd.

Alnylam Pharmaceuticals

224.53
+0.12000.05%
Post-market: 224.530.00000.00%17:47 EDT
Volume:1.77M
Turnover:395.24M
Market Cap:29.96B
PE:39.96
High:225.90
Open:222.03
Low:218.39
Close:224.41
52wk High:495.55
52wk Low:197.81
Shares:133.43M
Float Shares:133.16M
Volume Ratio:1.20
T/O Rate:1.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.62
EPS(LYR):2.33
ROE:96.55%
ROA:12.34%
PB:22.12
PE(LYR):96.36

Loading ...

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-06-18

Reuters
·
Jun 18

Does Alnylam’s Generative AI Pact With Inceptive Nucleics Redraw The R&D Bull Case For ALNY?

Simply Wall St.
·
Jun 16

Alnylam to host 10th RNAi Roundtable webcast series on pipeline updates

Reuters
·
Jun 12

Alnylam, Genesis Pharma Expand Commercial Partnership Into 4 Nordic Markets

MT Newswires Live
·
Jun 10

Genesis Pharma: Extended Agreement With Alnylam Pharmaceuticals NOW Includes Denmark, Finland, Norway, and Sweden

THOMSON REUTERS
·
Jun 10

Genesis Pharma Expands Strategic Commercial Partnership With Alnylam Pharmaceuticals for Rnai Therapeutics to Nordic Region

THOMSON REUTERS
·
Jun 10

Alnylam expands GENESIS Pharma commercialization partnership to Nordic markets

Reuters
·
Jun 10

Bloom Energy, Astera Labs, Alnylam, Reddit Could Be Among Next Adds to S&P 500

Dow Jones
·
Jun 09

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-06-08

Reuters
·
Jun 08

Alnylam Pharmaceuticals Price Target Maintained With a $510.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 05

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Fractyl Health, Inc. (GUTS)

TIPRANKS
·
Jun 05

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-06-04

Reuters
·
Jun 04

Alnylam And Inceptive Form Strategic AI Collaboration To Accelerate Discovery Of RNAi Therapeutics

Reuters
·
Jun 04

Alnylam Commits Up to $2B to AI-Driven Therapeutic Innovation -- Company Talk

Dow Jones
·
Jun 04

Alnylam Collaboration Aims to Accelerate Timelines For Drug Discovery -- Company Talk

Dow Jones
·
Jun 04

Alnylam, Inceptive form strategic AI collaboration

TIPRANKS
·
Jun 04

Alnylam partners with Inceptive in AI-driven RNAi drug discovery deal worth up to $2 billion

Reuters
·
Jun 04

Alnylam Pharmaceuticals - Co and Inceptive Collaboration Valued at up to $2 Bln With $30 Mln Upfront

THOMSON REUTERS
·
Jun 04

Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of Rnai Therapeutics

THOMSON REUTERS
·
Jun 04

Alnylam director David E.I. Pyott disposes of USD 1.14 million in common shares

Reuters
·
Jun 04